Perez-Chacon G, Zapata J
Front Immunol. 2021; 12:627602.
PMID: 33912159
PMC: 8072112.
DOI: 10.3389/fimmu.2021.627602.
Miao Y, Medeiros L, Xu-Monette Z, Li J, Young K
Front Oncol. 2019; 9:107.
PMID: 30881917
PMC: 6406015.
DOI: 10.3389/fonc.2019.00107.
Warren C, Wong-Brown M, Bowden N
Cell Death Dis. 2019; 10(3):177.
PMID: 30792387
PMC: 6384907.
DOI: 10.1038/s41419-019-1407-6.
Perez-Chacon G, Adrados M, Vallejo-Cremades M, Lefebvre S, Reed J, Zapata J
Front Immunol. 2019; 9:3114.
PMID: 30687320
PMC: 6338067.
DOI: 10.3389/fimmu.2018.03114.
Zhan W, Hu X, Yi J, An Q, Huang X
Mol Med Rep. 2015; 11(6):4142-8.
PMID: 25672487
PMC: 4394964.
DOI: 10.3892/mmr.2015.3326.
Role of miR-15/16 in CLL.
Pekarsky Y, Croce C
Cell Death Differ. 2014; 22(1):6-11.
PMID: 24971479
PMC: 4262785.
DOI: 10.1038/cdd.2014.87.
miR deregulation in CLL.
Balatti V, Pekarky Y, Rizzotto L, Croce C
Adv Exp Med Biol. 2013; 792:309-25.
PMID: 24014303
PMC: 4088930.
DOI: 10.1007/978-1-4614-8051-8_14.
Does the expression of BCL2 have prognostic significance in malignant peritoneal mesothelioma?.
Pillai K, Pourgholami M, Chua T, Morris D
Am J Cancer Res. 2013; 3(3):312-22.
PMID: 23841030
PMC: 3696537.
TNFR-associated factor 2 deficiency in B lymphocytes predisposes to chronic lymphocytic leukemia/small lymphocytic lymphoma in mice.
Perez-Chacon G, Llobet D, Pardo C, Pindado J, Choi Y, Reed J
J Immunol. 2012; 189(2):1053-61.
PMID: 22711886
PMC: 3526975.
DOI: 10.4049/jimmunol.1200814.
An optically pure apogossypolone derivative as potent pan-active inhibitor of anti-apoptotic bcl-2 family proteins.
Wei J, Stebbins J, Kitada S, Dash R, Zhai D, Placzek W
Front Oncol. 2012; 1:28.
PMID: 22655238
PMC: 3356046.
DOI: 10.3389/fonc.2011.00028.
Quantitative expression analysis of the apoptosis-related genes BCL2, BAX and BCL2L12 in gastric adenocarcinoma cells following treatment with the anticancer drugs cisplatin, etoposide and taxol.
Korbakis D, Scorilas A
Tumour Biol. 2012; 33(3):865-75.
PMID: 22238053
DOI: 10.1007/s13277-011-0313-z.
The immunoglobulin heavy chain gene 3' enhancers induce Bcl2 deregulation and lymphomagenesis in murine B cells.
Xiang H, Noonan E, Wang J, Duan H, Ma L, Michie S
Leukemia. 2011; 25(9):1484-93.
PMID: 21606958
PMC: 3162065.
DOI: 10.1038/leu.2011.115.
Synthesis and biological evaluation of Apogossypolone derivatives as pan-active inhibitors of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteins.
Wei J, Kitada S, Stebbins J, Placzek W, Zhai D, Wu B
J Med Chem. 2010; 53(22):8000-11.
PMID: 21033669
PMC: 3059195.
DOI: 10.1021/jm100746q.
Molecular basis of CLL.
Pekarsky Y, Zanesi N, Croce C
Semin Cancer Biol. 2010; 20(6):370-6.
PMID: 20863894
PMC: 2997849.
DOI: 10.1016/j.semcancer.2010.09.003.
Quantitative analysis of BCL2 mRNA expression in nasopharyngeal carcinoma: an unfavorable and independent prognostic factor.
Fendri A, Kontos C, Khabir A, Mokdad-Gargouri R, Ardavanis A, Scorilas A
Tumour Biol. 2010; 31(5):391-9.
PMID: 20514538
DOI: 10.1007/s13277-010-0047-3.
BI-97C1, an optically pure Apogossypol derivative as pan-active inhibitor of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteins.
Wei J, Stebbins J, Kitada S, Dash R, Placzek W, Rega M
J Med Chem. 2010; 53(10):4166-76.
PMID: 20443627
PMC: 2880850.
DOI: 10.1021/jm1001265.
13q14 deletions in CLL involve cooperating tumor suppressors.
Palamarchuk A, Efanov A, Nazaryan N, Santanam U, Alder H, Rassenti L
Blood. 2010; 115(19):3916-22.
PMID: 20071661
PMC: 2869560.
DOI: 10.1182/blood-2009-10-249367.
Inherited predisposition to chronic lymphocytic leukemia.
Brown J
Expert Rev Hematol. 2009; 1(1):51-61.
PMID: 19802369
PMC: 2732130.
DOI: 10.1586/17474086.1.1.51.
Apogossypol derivatives as pan-active inhibitors of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteins.
Wei J, Kitada S, Rega M, Stebbins J, Zhai D, Cellitti J
J Med Chem. 2009; 52(14):4511-23.
PMID: 19555126
PMC: 2747480.
DOI: 10.1021/jm900472s.
Apogossypol derivatives as antagonists of antiapoptotic Bcl-2 family proteins.
Wei J, Kitada S, Rega M, Emdadi A, Yuan H, Cellitti J
Mol Cancer Ther. 2009; 8(4):904-13.
PMID: 19372563
PMC: 2750823.
DOI: 10.1158/1535-7163.MCT-08-1050.